
What the Purdue Pharma Case Teaches Us About Reputational Tornadoes
Published: | Updated:
Purdue Pharma and its corporate leadership featured prominently in the media recently as litigation mounts over their sales and marketing of Oxycontin. Nir Kossovsky offers some observations about the lessons this situation provides for all corporate leaders responsible for their companies’ reputations.

